Page 45 - MI-2-4

Microbes & Immunity Pulmonary immunity: Pathogens versus protectors

of new anti-infective. In: Innate Immunity - New Perspectives Treat Strategies Med. 2024;3(1):1-5.
and Therapeutic Opportunities. London: IntechOpen; 2024.
doi: 10.4103/jpdtsm.jpdtsm_119_23
doi: 10.5772/intechopen.1006935
17. Mu P, Zhou S, Lv T, et al. Newly developed 3D in vitro models
6. Mojahed M, Besharati S, Farzanegan B, et al. Identification to study tumor-immune interaction. J Exp Clin Cancer Res.
of operational errors in the stages of the hemovigilance 2023;42(1):81.
program with the guidance of the Global Trigger Tool doi: 10.1186/s13046-023-02653-w
and comparing it with the reported errors. Sci J Iran Blood
Transfus Organ. 2024;21(4):320-332. 18. Zong Y, Li H, Liao P, et al. Mitochondrial dysfunction:
Mechanisms and advances in therapy. Signal Transduct
7. Li R, Li J, Zhou X. Lung microbiome: New insights into the Target Ther. 2024;9(1):124.
pathogenesis of respiratory diseases. Signal Transduct Target
Ther. 2024;9(1):19. doi: 10.1038/s41392-024-01839-8
doi: 10.1038/s41392-023-01722-y 19. Zhou X, Wu Y, Zhu Z, et al. Mucosal immune response in
biology, disease prevention and treatment. Signal Transduct
8. Fröhlich E. Non-cellular layers of the respiratory tract: Target Ther. 2025;10(1):7.
Protection against pathogens and target for drug delivery.
Pharmaceutics. 2022;14(5):992. doi.org/10.1038/s41392-024-02043-4
doi: 10.3390/pharmaceutics14050992 20. Mochan E, Sego T. Mathematical modeling of the lethal
synergism of coinfecting pathogens in respiratory viral
9. Zhang H, He F, Li P, Hardwidge PR, Li N, Peng Y. The role of infections: A review. Microorganisms. 2023;11(12):2974.
innate immunity in pulmonary infections. BioMed Res Int.
2021;2021(1):6646071. doi: 10.3390/microorganisms11122974
doi: 10.1155/2021/6646071 21. Qadri H, Shah AH, Almilaibary A, Mir MA. Microbiota,
natural products, and human health: Exploring interactions
10. Bizimana Rukundo T. Cross-reactivity in adaptive for therapeutic insights. Front Cell Infect Microbiol.
immunity: An overview. Appl Sci (NIJBAS). 2024;5(3):39-43.
2024;14:1371312.
doi: 10.59298/NIJBAS/2024/5.3.394311
doi: 10.1038/s41392-024-02043-4
11. Whiteside SA, McGinniss JE, Collman RG. The lung 22. Chiu CW, Tsai PJ, Lee CC, Ko WC, Hung YP. Application
microbiome: Progress and promise. J Clin Investig. of microbiome management in therapy for Clostridioides
2021;131(15):e150473.
difficile Infections: From fecal microbiota transplantation
doi: 10.1172/JCI150473 to probiotics to microbiota-preserving antimicrobial agents.
Pathogens. 2021;10(6):649.
12. Gillissen A, Paparoupa M. Inflammation and infections in
asthma. Clin Respir J. 2015;9(3):257-269. 23. Land WG. The DAMP-driven host immune defense program
against pathogens. In: Damage-Associated Molecular
doi: 10.1111/crj.12135
Patterns in Human Diseases: Antigen-Related Disorders.
13. Muyayalo KP, Gong GS, Kiyonga Aimeé K, Liao AH. Vol. 3. Germany: Springer; 2023. p. 203-284.
Impaired immune response against SARS-CoV-2 infection
is the major factor indirectly altering reproductive function doi: 10.1007/978-3-031-21776-0_4
in COVID-19 patients: A narrative review. Hum Fertil 24. Meng X, Layhadi JA, Keane ST, Cartwright NJ,
(Camb). 2023;26(4):778-796. Durham SR, Shamji MH. Immunological mechanisms of
tolerance: Central, peripheral and the role of T and B cells.
doi: 10.1080/14647273.2023.2262757
Asia Pac Allergy. 2023;13(4):175-186.
14. Saeid AB, De Rubis G, Williams KA, et al. Revolutionising
lung health: Exploring the latest breakthroughs and future doi: 10.5415/apallergy.0000000000000128
prospects of synbiotic nanostructures in lung diseases. 25. Besharati S, Aghajani J, Farnia P, et al. Association between
Chem Biol Interact. 2024;395:111009. the Vitamin D Receptor Gene (FokI, BsmI, ApaI, and TaqI)
polymorphism in health-care workers and susceptibility to
doi: 10.1016/j.cbi.2024.111009
COVID-19. Biomed Biotechnol Res J (BBRJ). 2023;7(3):404-410.
15. FarniaTP, Ghanavi J, Besharati S, Farnia P, Velayati AA. The
pili at genomic level. Pili in Mycobacterium Tuberculosis: doi: 10.4103/bbrj.bbrj_133_23
Structure, Function, and Therapeutic Advances. Netherlands: 26. Farnia P, Besharati S, Farina P, et al. The role of efflux
Elsevier; 2024. p. 161. pumps transporter in multi-drug resistant tuberculosis:
Mycobacterial memberane protein (MmpL5). Int J
16. Fouladi MD, Besharati S, Farnia P, Khosravi A. A concise
review of the effect of efflux pump on biofilm intensity in Mycobacteriol. 2024;13(1):7-14.
bacteria with a special view to mycobacterium. J Prev Diagn doi: 10.4103/ijmy.ijmy_37_24

Volume 2 Issue 4 (2025) 37 doi: 10.36922/MI025100019